icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Early Viral Kinetics Do Not Predict Treatment Outcome With Sofosbuvir + Ribavirin for 12 or 24 Weeks in HCV Genotype 2/3 Patients in the VALENCE Trial
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Stefan Zeuzem,1 Geoffrey M. Dusheiko,2 Massimo Colombo,3 Robert Flisiak,4 Robert H. Hyland,5 Ari Illeperuma,5 Diana M. Brainard,5 William T. Symonds,5 John G. McHutchison,5 Ola Weiland,6 Hendrik W. Reesink,7 Ashley Brown,8 Stanislas Pol,9 Christophe Hezode,10 Rafael Esteban11 1Johann Wolfgang Goethe University, Frankfurt, Germany; 2Royal Free and University College School of Medicine, Royal Free Hospital, London, UK; 3University of Milan, Italy; 4Medical University of Bialystok, Poland; 5Gilead Sciences, Inc., Foster City, California, USA; 6Karolinska Institutet, Karolinska University Hospital Huddinge,
Stockholm, Sweden; 7Academic Medical Center, Amsterdam, the Netherlands; 8Imperial College Healthcare NHS Trust, London; 9Hôpital Cochin, Paris, France; 10Centre Hospitalier Universitaire Henri Mondor de Créteil, France; 11Hospital Universitario Vall d'Hebron, Barcelona, Spain

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif